You are here: Industry Insights > shingle

News List

Global Shingles (Herpes Zoster) Market Trends and Prospects David Orchard-Webb
March 18, 2025
The global shingles market is growing due to factors like an aging population. It elaborates on drivers, segmentation, competition, and future trends.
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S. PR Newswire
February 25, 2025
Another Step Forward in Global Expansion
GSK Singapore announces availability of Shingrix in Singapore for shingles prevention prnasia
January 10, 2022
GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore.
Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine WorldPharmaNews
January 07, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles...
Pfizer and BioNTech enter deal to develop first mRNA vaccine for shingles Pharmaceutical-Technology
January 07, 2022
Pfizer and BioNTech have entered a new research, development and marketing partnership for a potential first mRNA-based vaccine to prevent shingles (herpes zoster virus (HZV)).
US FDA approves Shingrix to prevent shingles in immuno-compromised adults expresspharma
July 28, 2021
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA in 2017 for the prevention of shingles in adults 50 years of age or older.
Shingrix Approved for Shingles Prevention in Immunocompromised Adults americanpharmaceuticalreview
July 27, 2021
GlaxoSmithKline plc announced that the US FDA has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to ...
Chickenpox Vaccine Shields Kids From Shingles, Too drugs
June 11, 2019
Chickenpox Vaccine Shields Kids From Shingles, Too.
China approves GSK’s shingles vaccine Shingrix in adults pharmaceutical-technology
May 29, 2019
GlaxoSmithKline (GSK) has received approval from the Chinese National Medical Products Administration (NMPA) for the use of its Shingrix vaccine to prevent shingles (herpes zoster) in adults.
NanoViricides Reaches Agreement on Terms of License for Shingles Virus Drug Development americanpharmaceuticalreview
February 27, 2019
NanoViricides has reached an agreement on the terms of the license for the drug development against VZV, the virus that causes chickenpox in children and shingles in adults....